Compile Data Set for Download or QSAR
Report error Found 20 of affinity data for UniProtKB/TrEMBL: Q0GMK6
TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM50420304(CHEMBL2089065 | US8598217, 165)
Affinity DataIC50: 3nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM107751(CHEMBL2089063 | US8598217, 89)
Affinity DataIC50: 4nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM107755(US8598217, 140)
Affinity DataIC50: 4nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM107761(US8598217, 174)
Affinity DataIC50: 5nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM107765(US8598217, 166)
Affinity DataIC50: 8nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM50420305(CHEMBL2089057 | US8598217, 173)
Affinity DataIC50: 12nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM50420303(CHEMBL2089064 | US8598217, 135)
Affinity DataIC50: 12nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM107756(US8598217, 163)
Affinity DataIC50: 14nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM107757(US8598217, 164)
Affinity DataIC50: 24nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM107753(US8598217, 99)
Affinity DataIC50: 26nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM107750(US8598217, 86)
Affinity DataIC50: 27nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM107752(US8598217, 98)
Affinity DataIC50: 33nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM107749(US8598217, 84)
Affinity DataIC50: 57nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM107754(US8598217, 103)
Affinity DataIC50: 60nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM107764(US8598217, 148)
Affinity DataIC50: 67nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM107762(US8598217, 182)
Affinity DataIC50: 77nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM107763(US8598217, 189)
Affinity DataIC50: 95nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM107758(US8598217, 167)
Affinity DataIC50: 195nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM107759(US8598217, 169)
Affinity DataIC50: 260nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4(Rabbit)
Astex Therapeutics

US Patent
LigandPNGBDBM107760(US8598217, 170)
Affinity DataIC50: 548nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
Go to US Patent